These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1911532)

  • 1. Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas' disease.
    Minoprio P; Coutinho A; Spinella S; Hontebeyrie-Joskowicz M
    Int Immunol; 1991 May; 3(5):427-33. PubMed ID: 1911532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant association between the skewed natural antibody repertoire of Xid mice and resistance to Trypanosoma cruzi infection.
    Santos-Lima EC; Vasconcellos R; Reina-San-Martín B; Fesel C; Cordeiro-Da-Silva A; Berneman A; Cosson A; Coutinho A; Minoprio P
    Eur J Immunol; 2001 Feb; 31(2):634-45. PubMed ID: 11180129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent.
    Minoprio P; el Cheikh MC; Murphy E; Hontebeyrie-Joskowicz M; Coffman R; Coutinho A; O'Garra A
    J Immunol; 1993 Oct; 151(8):4200-8. PubMed ID: 8409396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V beta 6-bearing T cells are involved in resistance to Trypanosoma cruzi infection in XID mice.
    Cordeiro da Silva A; Lima EC; Vicentelli MH; Minoprio P
    Int Immunol; 1996 Aug; 8(8):1213-9. PubMed ID: 8918690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulatory mechanisms and Chagas' disease.
    Hontebeyrie-Joskowicz M
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():101-3. PubMed ID: 1342703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.
    Bryan MA; Guyach SE; Norris KA
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e733. PubMed ID: 20625554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
    Gironès N; Cuervo H; Fresno M
    Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.
    Hernández-Munaín C; De Diego JL; Alcina A; Fresno M
    J Exp Med; 1992 Jun; 175(6):1473-82. PubMed ID: 1375261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-antibody-mediated control of parasitemia in acute experimental Chagas' disease.
    Trischmann TM
    J Immunol; 1983 Apr; 130(4):1953-7. PubMed ID: 6403614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chagas' disease: Trypanosoma cruzi vs. the host immune system.
    Hontebeyrie-Joskowicz M; Minoprio P
    Res Immunol; 1991 Feb; 142(2):125-6. PubMed ID: 1907752
    [No Abstract]   [Full Text] [Related]  

  • 13. Cloning of B cells from autoimmune MRL-lpr/lpr and MRL.xid mice.
    Pisetsky DS; Caster SA; Piper M; Scott DW; Steinberg AD
    Cell Immunol; 1984 Mar; 84(1):32-40. PubMed ID: 6607779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.
    Brener Z; Gazzinelli RT
    Int Arch Allergy Immunol; 1997 Oct; 114(2):103-10. PubMed ID: 9338602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator.
    Da Silva AC; Espinoza AG; Taibi A; Ouaissi A; Minoprio P
    Immunology; 1998 Jun; 94(2):189-96. PubMed ID: 9741340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.
    Barry MA; Wang Q; Jones KM; Heffernan MJ; Buhaya MH; Beaumier CM; Keegan BP; Zhan B; Dumonteil E; Bottazzi ME; Hotez PJ
    Hum Vaccin Immunother; 2016 Apr; 12(4):976-87. PubMed ID: 26890466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic experimental Chagas' disease: functional syngeneic T-B-cell cooperation in vitro in the absence of an exogenous stimulus.
    Freire-de-Lima C; Peçanha LM; Dos Reis GA
    Infect Immun; 1996 Jul; 64(7):2861-6. PubMed ID: 8698526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAFF mediates splenic B cell response and antibody production in experimental Chagas disease.
    Bermejo DA; Amezcua-Vesely MC; Montes CL; Merino MC; Gehrau RC; Cejas H; Acosta-Rodríguez EV; Gruppi A
    PLoS Negl Trop Dis; 2010 May; 4(5):e679. PubMed ID: 20454564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
    Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
    Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5 B cells. Potential role in the (auto)immune responses to Trypanosoma cruzi infection.
    el Cheikh MC; Hontebeyrie-Joskowicz M; Coutinho A; Minoprio P
    Ann N Y Acad Sci; 1992 May; 651():557-63. PubMed ID: 1376076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.